Mylan Begins Marketing First Generic Version of Desoxyn

Mylan Inc. Monday announced that its subsidiary Mylan Pharmaceuticals Inc. has begun to market Methamphetamine Hydrochloride Tablets USP, 5 mg, based on an agreement with licensing partner Coastal Pharmaceuticals.
TheStreet